Reviewed by Nur Ayunis Binti Che Daud, Bionutricia
The word “liposomal” on a label proves nothing. Four measurements do: particle size with polydispersity index, zeta potential, encapsulation efficiency, and stability data across shelf life. Ask for all four — and for the method used to generate each — before you qualify a liposomal ingredient for a bulk purchase.
Quick facts
- Particle size & PDI — Z-average in nanometres plus polydispersity index, by dynamic light scattering (DLS)
- Zeta potential — surface charge in millivolts; an indicator of resistance to aggregation
- Encapsulation efficiency — percentage of active entrapped, measured after separating free active
- Stability — size drift, leakage, oxidation and appearance under real-time and accelerated storage
- Powder forms — also require redispersion behaviour after reconstitution
What “liposomal” actually means
A liposome is a closed vesicle whose wall is a phospholipid bilayer — two facing layers of phospholipid molecules, hydrophilic heads turned outward towards water on both sides and lipophilic tails turned inward towards each other. That architecture gives the structure two distinct compartments: an aqueous core that can carry water-soluble actives, and the lipid interior of the bilayer itself, which can carry lipid-soluble ones.
The distinction matters commercially because the term is used loosely. A phospholipid added to a powder blend is not a liposome. A coarse oil-in-water emulsion is not a liposome. Both may legitimately improve dispersibility or mouthfeel, but neither delivers the bilayer structure the word implies. The only thing that settles the question is measurement — which is what the rest of this guide is about. For the broader technology background, see our pillar on what Herbosomal® encapsulation is.
1. Particle size and polydispersity index
Vesicle size is measured by dynamic light scattering, which infers particle size from the way suspended particles scatter laser light as they move. Two numbers come out of it, and a credible specification states both:
- Z-average diameter, in nanometres — the intensity-weighted mean size of the population.
- Polydispersity index (PDI), a dimensionless number from 0 to 1 describing how wide the size distribution is. A low PDI indicates a narrow, uniform population; a high PDI indicates a mixture of very different sizes, which is what an inconsistent or partially collapsed preparation looks like.
A single size figure with no PDI beside it is a half-answer. So is a size measured once at manufacture and never again: the meaningful test is whether the same values still hold at the end of the stated shelf life. Ask for both timepoints.
2. Zeta potential
Zeta potential is the effective electrical charge at the vesicle surface, reported in millivolts and measured by electrophoretic light scattering. Its usefulness is as a stability indicator: vesicles carrying a strong like charge repel one another and stay dispersed, while a population whose charge sits close to zero has little to prevent aggregation and fusion over time.
It is a directional indicator rather than a pass/fail line, and it must be read together with the medium it was measured in, because pH and ionic strength move the number. A zeta value quoted with no measurement conditions is not interpretable. Where a supplier reports zeta potential at all, it is usually a sign that the product has been characterised properly rather than merely mixed.
3. Encapsulation efficiency — the number most specs omit
This is the measurement that separates encapsulation from marketing. Encapsulation efficiency is the proportion of the total active that is genuinely entrapped within the vesicles, as opposed to dissolved in the surrounding medium. Determining it requires a separation step — ultrafiltration, dialysis, size-exclusion chromatography or ultracentrifugation — to remove free active before the entrapped fraction is assayed.
That extra work is exactly why the number is so often absent. A total-content assay is simple and tells you how much active is in the container; it says nothing about how much of it is encapsulated. A product can pass a total-content specification handsomely while being, in practice, a suspension of unencapsulated material.
Two follow-up questions are worth asking whenever an efficiency figure is given: which separation method was used, since results are not directly comparable across methods, and was it re-measured at end of shelf life, since actives leak out of vesicles over time and a day-one figure describes a product you will never receive.
4. Stability — and the powder question
Liposomal systems fail gradually and in characteristic ways: vesicles aggregate and fuse, so the Z-average climbs and the PDI widens; entrapped active leaks into the surrounding medium, so encapsulation efficiency falls; unsaturated phospholipids oxidise, which shows up as rising peroxide value and off-odour; and the product may separate, cream or discolour. A stability package should track all of these, under real-time storage at the stated condition and under accelerated conditions, not simply re-run the potency assay.
Powdered liposomal ingredients add one more question. Converting a liposomal dispersion into a free-flowing powder means drying it, and drying is the point at which vesicle structure is most at risk. The measurement that matters for a powder is therefore what happens on reconstitution: does the material redisperse to the same particle size and PDI it had before drying, or does it come back as something coarser? A liposomal powder that has never been characterised after reconstitution has not really been characterised at all.
Carrier choice matters here too. Bionutricia uses arabic gum as the emulsifier across our powders — never sodium caseinate or synthetic emulsifiers. Sodium caseinate is milk-derived, which makes it a declarable allergen, rules out vegan and dairy-free positioning, and complicates halal review. Arabic gum avoids all three, and is itself a soluble dietary fibre.
Reading a liposomal specification: what good looks like
| Parameter | What a strong specification states |
|---|---|
| Particle size | Z-average in nm and PDI, with the method (DLS) and the dispersion medium named |
| Zeta potential | Value in mV with pH and ionic conditions stated |
| Encapsulation efficiency | Percentage entrapped, with the separation method named and the assay identified |
| Stability | Size, PDI, encapsulation efficiency, peroxide value and appearance at time zero and at end of shelf life |
| Reconstitution (powders) | Particle size and PDI re-measured after redispersion |
| Active content | Assay of the active by a stated method, batch-specific |
| Carrier and emulsifier | Declared, with allergen and dietary status clear |
| Contaminants | Heavy metals, microbial panel and, where relevant, residue data on the finished material |
Red flags
- “Liposomal” with no particle-size data at all. The claim is unverified by definition.
- A size figure with no PDI. Hides how wide the distribution really is.
- No encapsulation efficiency. The most commonly omitted and most revealing number.
- Stability data limited to potency. Potency can hold while the vesicle population quietly collapses.
- A powder characterised only before drying. Says nothing about what the customer actually receives.
- Bioavailability multiples with no reference. An unsupported multiplier is a marketing number, not a specification.
How Bionutricia approaches liposomal quality
Bionutricia has manufactured standardised botanical extracts and liposomal ingredients in Malaysia since 2006, from our Sungai Buloh, Selangor facility, under FSSC 22000, GMP, HACCP, JAKIM Halal, US FDA registration and MeSTI, together with NanoVerify certification.
Our liposomal encapsulation and sustained-release technology is branded Herbosomal®, a registered trademark, and is patent-pending under application PI2023005773. It sits alongside our granted enzymatic and ultrasonic extraction process patent, MY-188945-A, which covers the extraction and powder-preparation process rather than the encapsulation technology. Each liposomal lot is released against a batch-specific Certificate of Analysis, and characterisation data — particle size, polydispersity, encapsulation efficiency and stability — is available to qualified B2B buyers on request.
Bionutricia supplies the bulk ingredient for B2B formulation; brand owners and manufacturers formulate it into their chosen finished format, whether capsules, tablets, sachets, beverages or dairy applications.
Need characterisation data for a specific liposomal ingredient?
Related guides
Frequently asked questions
What makes an ingredient genuinely liposomal?
A liposome is a vesicle formed by a phospholipid bilayer enclosing an aqueous core. The word only means something if the supplier can evidence vesicle formation and size with a measurement such as dynamic light scattering. A simple emulsion or a phospholipid blend is not a liposome, even when it is sold under a liposomal name.
What particle size should a liposomal ingredient be?
There is no universal figure; the right target depends on the active and the application. What matters is that a Z-average size and a polydispersity index are both stated, that the method is named, and that the same values are re-measured at the end of shelf life to show the population has not drifted.
What is encapsulation efficiency, and why is it usually missing?
Encapsulation efficiency is the proportion of the active actually entrapped in the vesicles rather than floating free in the surrounding medium. It requires separating free from entrapped active before assay, which is more work than a simple total-content test, so many specifications quietly omit it. It is the number that tells you whether you are buying encapsulation or just a mixture.
What does zeta potential tell a buyer?
Zeta potential is the surface charge of the vesicles, reported in millivolts. A larger magnitude means stronger electrostatic repulsion between vesicles and less tendency to aggregate, so it is read as an indicator of colloidal stability. Values approaching zero suggest a population that may aggregate over time.
What is Herbosomal and how does it relate to liposomal delivery?
Herbosomal is Bionutricia’s registered trademark for our liposomal encapsulation and sustained-release technology, which is patent-pending under application PI2023005773. It is applied across our liposomal range, and full particle-size, encapsulation-efficiency and stability data for a given product is available to qualified B2B buyers on request.
